由丁诺波纳毒素M-PONTX-Dq4e衍生的tcGAPDH基抑制剂,具有三酸性作用
Emanuel Paula Magalhães1, Dânya Bandeira Lima1, Evelline Araújo Edson2
1Postgraduate Programm on Pharmaceutical Sciences, Federal University of Ceará, Brazil.
Toxicon : official journal of the International Society on Toxinology
|December 20, 2025
概括
来自M-PONTX-Dq4e的新型体对Trypanosoma cruzi表现出强烈的tripanocidal活性,为Chagas提供了一个对benznidazole的有希望的替代品.
科学领域:
- 寄生虫学的寄生虫学
- 药用化学 医学化学
- 生物技术是生物技术.
背景情况:
- 查加斯病 (CD) 治疗受到本兹尼达的疗效和毒性限制.
- 草甘-3-酸脱酶 (TcGAPDH) 是一个经过验证的治疗点.
- 像M-PONTX-Dq4e这样的抗微生物显示出三毒性潜力,但需要优化.
研究的目的:
- 开发具有增强抗T. cruzi活性的新型,更短,更少的细胞毒性M-PONTX-Dq4e衍生.
- 研究作用机制,包括TcGAPDH抑制.
- 确定用于改善查加斯病治疗的化合物.
主要方法:
- M-PONTX-Dq4e片段和类似物的固体相合成.
- 在体外对宿主细胞的细胞毒性 (LLC-MK2) 和对T. cruzi. cruzi.的tripanocidal活性进行了评估.
- 在体和体外分析TcGAPDH抑制和作用机制 (ROS,线粒体功能障碍).
主要成果:
- M-PONTX-Dq4e [1-10] 片段显示出有前途的活性和降低细胞毒性.
- 合成的类似物,特别是[F]9 M-PONTX-Dq4e [1-10],表现出优越的抗T. cruzi疗效和选择性 (对阿马斯蒂戈特的SI>152.1).
- 同类药物诱导了膜损伤,ROS积累,线粒体功能障碍,并抑制了TcGAPDH活性.
结论:
- 理性设计产生了强大的M-PONTX-Dq4e衍生型三酸,具有更好的治疗潜力.
- [F]9 M-PONTX-Dq4e [1-10] 是一种高度选择性和有效的化合物,可以对抗T. cruzi.的形状.
- 这些新型代表了开发下一代查加斯病治疗的有希望的途径.
更多相关视频
09:49Determination of Chemical Inhibitor Efficiency against Intracellular Toxoplasma Gondii Growth Using a Luciferase-Based Growth Assay
Published on: April 29, 2020
7.6K
08:48In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase
Published on: November 5, 2021
3.7K
相关概念视频
Dipeptidyl Peptidase 4 Inhibitors
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a significant...
Inhibitors of Gram-positive Cell Wall Synthesis
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Inhibitors of Bacterial DNA Synthesis
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
